Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Revelation Biosciences, Inc. (REVB) had Free Cash Flow per Share of $-106.63 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-15.04M |
|
-- |
|
-- |
|
$7.98M |
|
$-7.98M |
|
$-7.06M |
|
$-15.04M |
|
$-15.04M |
|
$-15.04M |
|
$-15.04M |
|
$-15.04M |
|
$-15.04M |
|
$-7.98M |
|
$-7.95M |
|
0.17M |
|
0.17M |
|
$-87.68 |
|
$-87.68 |
|
| Balance Sheet Financials | |
$6.57M |
|
$0.06M |
|
$0.06M |
|
$6.62M |
|
$1.91M |
|
-- |
|
-- |
|
$1.91M |
|
$4.71M |
|
$4.71M |
|
$4.71M |
|
0.52M |
|
| Cash Flow Statement Financials | |
$-18.32M |
|
$-0.02M |
|
$12.85M |
|
$11.99M |
|
$6.50M |
|
$-5.49M |
|
$0.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.43 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.34M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-319.40% |
|
-319.40% |
|
-227.10% |
|
-319.40% |
|
$9.02 |
|
|
Free Cash Flow per Share |
$-106.63 |
$-106.52 |
|